Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Can we optimize selective screening of gestational diabetes mellitus? A multivariable predictive model on population-based data from the French National Perinatal Surveys.

Created on 25 Jul 2026

Authors

Lyn Badra, Jérémie F Cohen, Marie Viaud, Nolwenn Regnault, Nathalie Lelong, Camille Le Ray, ENP2021 Study Group

Published in

Journal of gynecology obstetrics and human reproduction. Pages 103244. Jul 24, 2026. Epub Jul 24, 2026.

Abstract

Selective screening for gestational diabetes mellitus (GDM) remains a widespread strategy. Variation in criteria identifying at-risk women questions its accuracy, with implications for clinical outcome and resource allocation. Our aim was to develop and externally validate a multivariable prediction model with improved performance compared to the current French pre-screening selection strategy.
Data was derived from the population-based 2021 (derivation sample) and 2016 (external validation sample) French National Perinatal Survey (ENP). Independent predictors of GDM were identified using a multivariable logistic regression model. Predictive performance was assessed through the area under the receiver operating characteristic curve. Diagnostic performance was assessed through sensitivity, specificity, and accuracy. Sensitivity analyses were conducted: (1) in maternity centers with quasi-universal screening, (2) outcome strictly defined as GDM cases associated with large-for-gestational-age births and (3) implementing doubly robust estimators of sensitivity and specificity.
The study population included 10834 women in the derivation sample and 11633 in the validation sample, where the prevalence of GDM was respectively 19.4% and 13.2%. Maternal age, body mass index, obstetric history, family history of diabetes, and maternal country of birth were independent predictors of GDM. The prediction model demonstrated a statistically significant improvement in specificity (0.49 [95% CI: 0.48-0.50] vs. 0.46 [95% CI: 0.45-0.47]) and overall diagnostic accuracy (0.53 [95% CI: 0.52-0.54] vs. 0.50 [95% CI: 0.49-0.51]).
The prediction model modestly improved performance while maintaining the same screening rate, though it is unlikely to justify additional complexity of implementation, therefore limiting its added-value in clinical practice. These findings suggest that available clinical predictors already capture most of the predictive information relevant for selective screening.

PMID:
42497958
Bibliographic data and abstract were imported from PubMed on 25 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement